Two Sigma Advisers’s Meridian Bioscience Inc VIVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-265,800
| Closed | -$8.83M | – | 2841 |
|
|
2022
Q4 | $8.83M | Buy |
265,800
+216,900
| +444% | +$6.99M | 0.02% | 555 |
|
|
2022
Q3 | $1.54M | Sell |
48,900
-78,100
| -61% | -$2.53M | ﹤0.01% | 1307 |
|
|
2022
Q2 | $3.86M | Buy |
127,000
+45,100
| +55% | +$1.22M | 0.01% | 881 |
|
|
2022
Q1 | $2.13M | Buy |
81,900
+9,800
| +14% | +$233K | 0.01% | 1223 |
|
|
2021
Q4 | $1.47M | Buy |
72,100
+7,100
| +11% | +$136K | ﹤0.01% | 1349 |
|
|
2021
Q3 | $1.25M | Sell |
65,000
-16,900
| -21% | -$337K | ﹤0.01% | 1509 |
|
|
2021
Q2 | $1.82M | Sell |
81,900
-48,600
| -37% | -$1.03M | ﹤0.01% | 1335 |
|
|
2021
Q1 | $3.43M | Buy |
130,500
+15,300
| +13% | +$364K | 0.01% | 1022 |
|
|
2020
Q4 | $2.15M | Sell |
115,200
-146,800
| -56% | -$2.74M | 0.01% | 1216 |
|
|
2020
Q3 | $4.45M | Sell |
262,000
-123,200
| -32% | -$2.39M | 0.01% | 806 |
|
|
2020
Q2 | $8.97M | Buy |
385,200
+145,900
| +61% | +$2.11M | 0.03% | 592 |
|
|
2020
Q1 | $2.01M | Buy |
239,300
+134,800
| +129% | +$1.13M | 0.01% | 1117 |
|
|
2019
Q4 | $1.02M | Buy |
104,500
+51,675
| +98% | +$485K | ﹤0.01% | 1569 |
|
|
2019
Q3 | $501K | Sell |
52,825
-58,900
| -53% | -$621K | ﹤0.01% | 1712 |
|
|
2019
Q2 | $1.33M | Sell |
111,725
-38,315
| -26% | -$462K | ﹤0.01% | 1389 |
|
|
2019
Q1 | $2.64M | Sell |
150,040
-48,100
| -24% | -$800K | 0.01% | 1099 |
|
|
2018
Q4 | $3.44M | Sell |
198,140
-6,801
| -3% | -$116K | 0.01% | 939 |
|
|
2018
Q3 | $3.05M | Sell |
204,941
-54,100
| -21% | -$839K | 0.01% | 1026 |
|
|
2018
Q2 | $4.12M | Buy |
259,041
+31,900
| +14% | +$476K | 0.01% | 931 |
|
|
2018
Q1 | $3.23M | Sell |
227,141
-6,600
| -3% | -$97.7K | 0.01% | 1036 |
|
|
2017
Q4 | $3.27M | Buy |
233,741
+5,900
| +3% | +$86.4K | 0.01% | 1024 |
|
|
2017
Q3 | $3.26M | Buy |
227,841
+17,161
| +8% | +$245K | 0.01% | 979 |
|
|
2017
Q2 | $3.32M | Sell |
210,680
-25,561
| -11% | -$368K | 0.01% | 945 |
|
|
2017
Q1 | $3.26M | Buy |
236,241
+163,716
| +226% | +$2.29M | 0.01% | 1008 |
|
|
2016
Q4 | $1.28M | Buy |
72,525
+33,600
| +86% | +$590K | ﹤0.01% | 1426 |
|
|
2016
Q3 | $751K | Buy |
38,925
+9,200
| +31% | +$180K | ﹤0.01% | 1488 |
|
|
2016
Q2 | $580K | Buy |
+29,725
| New | +$583K | ﹤0.01% | 1457 |
|
|
2015
Q3 | – | Sell |
-94,425
| Closed | -$1.76M | – | 2037 |
|
|
2015
Q2 | $1.76M | Buy |
94,425
+3,700
| +4% | +$68.6K | 0.01% | 863 |
|
|
2015
Q1 | $1.73M | Buy |
90,725
+7,200
| +9% | +$133K | 0.01% | 839 |
|
|
2014
Q4 | $1.38M | Buy |
+83,525
| New | +$1.43M | 0.01% | 996 |
|
Other funds holding VIVO
Two Sigma Advisers's VIVO Position: Q1 2023 in Review
Two Sigma Advisers sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 265,800 shares — an estimated $8.83M sold.
Two Sigma Advisers first reported a position in VIVO in Q4 2014 and held it in 30 quarters. The position peaked at $8.97M in Q2 2020. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.
- Two Sigma Advisers reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
- Two Sigma Advisers sold 265,800 Meridian Bioscience Inc shares in Q1 2023, an estimated $8.83M.
- Two Sigma Advisers first reported a position in Meridian Bioscience Inc in Q4 2014 and held it in 30 quarters.
- Two Sigma Advisers's Meridian Bioscience Inc position peaked at $8.97M in Q2 2020.
- 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.
Based on Two Sigma Advisers's 13F filing for Q1 2023, filed 15 May 2023.